Validation of the French Version of the Fatigue Score "Brief Fatigue Inventory ( BFI)".

Fatigue Symptom Clinical Trial

— EAMG  

Official title:

Validation de la Version française du Score de Fatigue " Brief Fatigue Inventory (BFI)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02645812
• Other study ID #: EAMG- RB 14.062
• Status: Recruiting
• Phase: N/A
• First received: January 4, 2016
• Last updated: July 11, 2016
• Start date: March 2016
• Est. completion date: September 2017

Study information

• Verified date: June 2016
• Source: University Hospital, Brest
• Contact: Christian Berthou
• Email: christain.berthou[@]chu-brest.fr
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Fatigue, or asthenia, is an important symptom for the diagnosis and follow-up of patients in routine as well as research oriented clinical practice.

Various questionnaires measuring fatigue have been developed, but few have been validated in french. MFI (Multidimensional Fatigue Inventory) has been validated in french in only one study. BFI (Brief Fatigue Inventory) has been translated but never validated in french language.

The main purpose of this study is to validate psychometrically the french version of BFI.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1200
• Est. completion date: September 2017
• Est. primary completion date: September 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Consultation for fatigue as symptôme principal ( isolated or asociated with other symptomes).

Exclusion Criteria:

Pregnancy Psychosis. Unable to complete questionnaire Phsyiological fatigue due to effort and reversible rest. Post-traumatic stress disorder -

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Fatigue
• Fatigue Symptom

Locations

Country	Name	City	State
France	Cabinet Brest Centre	Brest
France	Cabinet Brest Centre	Brest
France	Cabinet Brest Centre	Brest
France	Cabinet Brest Centre	Brest
France	Cabinet Brest Centre	Brest
France	Cabinet Camaret/mer	Camaret/mer
France	Cabinet Ergue Gaberic	Ergue Gaberic
France	Cabinet Ergue Gaberic	Ergue Gaberic
France	Cabinet Ergue Gaberic	Ergue Gaberic
France	Cabinet Lamneur	Lanmeur
France	Cabinet Lamneur	Lanmeur
France	Cabinet Lanmeur	Lanmeur
France	Cabinet Lanmeur	Lanmeur
France	Cabinet Lanmeur	Lanmeur
France	Cabinet Le Guilvinec	Le Guilvinec
France	Cabinet Le Guilvinec	Le Guilvinec
France	Cabinet Le Guilvinec	Le Guilvinec
France	Cabinet Lesconil	Lesconil
France	Cabinet Penmarch	Penmarch
France	Cabinet Plouegat Guerrand	Plouegat Guerrand
France	Cabinet Quimper	Quimper
France	Cabinet Rosporden	Rosporden
France	Cabinet Rosporden	Rosporden

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	9 points of BFI, each of them between 0 to 10. of BFI		3 Months	No